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Visual search and identiﬁcation of analyzable metaphase chromosomes using optical microscopes is a very tedious and time-consum-
ing task that is routinely performed in genetic laboratories to detect and diagnose cancers and genetic diseases. The purpose of this study
is to develop and test a computerized scheme that can automatically identify chromosomes in metaphase stage and classify them into
analyzable and un-analyzable groups. Two independent datasets involving 170 images are used to train and test the scheme. The scheme
uses image ﬁltering, threshold, and labeling algorithms to detect chromosomes, followed by computing a set of features for each indi-
vidual chromosome as well as for each identiﬁed metaphase cell. Two machine learning classiﬁers including a decision tree (DT) based
on the features of individual chromosomes and an artiﬁcial neural network (ANN) using the features of the metaphase cells are opti-
mized and tested to classify between analyzable and un-analyzable cells. Using the DT based classiﬁer the Kappa coeﬃcients for agree-
ment between the cytogeneticist and the scheme are 0.83 and 0.89 for the training and testing datasets, respectively. We apply an
independent testing and a 2-fold cross-validation method to assess the performance of the ANN-based classiﬁer. The area under and
receiver operating characteristic (ROC) curve is 0.93 for the complete dataset. This preliminary study demonstrates the feasibility of
developing a computerized scheme to automatically identify and classify metaphase chromosomes.
 2007 Elsevier Inc. All rights reserved.
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Since Tjio and Levan discovered that the chromosome
number of human being was 46 in 1956 [1], the knowledge
about chromosomal abnormalities, as a cause of diseases,
increased enormously. For example, in 1960 Nowell and
Hungerford discovered a small chromosome marker, the
Philadelphia chromosome, in patients with chronic mye-
loid leukemia (CML) [2]. This is proved to be the ﬁrst con-
sistent chromosomal abnormality in human cancer and it
greatly stimulated interest in cancer cytogenetics. Cur-
rently, identiﬁcation and classiﬁcation of chromosomes1532-0464/$ - see front matter  2007 Elsevier Inc. All rights reserved.
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E-mail address: zhengb@upmc.edu (B. Zheng).using optical microscopic images is an important labora-
tory and clinical procedure to screen and diagnose genetic
disorders [3], cancers [4,5] and other diseases [6]. Speciﬁ-
cally, chromosome abnormalities and mutations are the
results of changes in chromosome structure. Studies have
found that consistent chromosomal changes led to isola-
tion of the genes involved in the cancer pathogenesis [7].
Detection of these consistent, recurrent chromosomal
changes has allowed the division of patients into clinical
groups which deﬁne their duration of remission and mean
survival time [8]. Hence, better understanding the mecha-
nism of abnormal chromosome can help oncologists evalu-
ate cancer prognosis and select more eﬀective treatment
procedures. For this purpose, karyotyping of metaphase
cells is the most common procedure to analyze and classify
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out of chromosomes organized by decreasing size in pairs
for each testing cell by the comparison between the chro-
mosomes identiﬁed in the cell and the chromosomes stored
in a pre-established standard database. Chromosomes are
assigned to each of the 24 classes [10]. Then, variety of dis-
eases, genetic disorders, and cancers, can be diagnosed
based on the possible distortion of the banded patterns
of diﬀerent chromosome pairs [11].
Before performing karyotyping and other diagnostic
procedures, a cytogenetic technologist uses an optical
microscope to visually examine each glass slide prepared
from samples (i.e., amniotic ﬂuid, blood sample, skin or
bone marrow) acquired from a patient to search for and
identify the cells with analyzable chromosomes. Because
the cells are very small (in the order of a few 100 lm),
the technologist must move the slide under the microscope
many times to thoroughly search the entire slide and fre-
quently switch between two microscopic objectives of low
(e.g., 10·) and high magniﬁcation power (e.g., 100·). It is
desirable to ﬁnd at least 20–30 analyzable metaphase chro-
mosome cells for each patient. Since, not all cells are
engaged in cell division and not all dividing cells are in
the analyzable metaphase stage, the technologist must look
at a large number of cells before a cell with clearly imaged
chromosomes can be found. Fig. 1 demonstrates two meta-
phase chromosome cells, one is considered analyzable and
one is un-analyzable by an experienced cytogeneticist. In
the clinical practice, examining as many as 5–10 micro-
scopic sample slides is typically needed for one patient.
Therefore, it takes tremendous eﬀort and time for the tech-
nologist to obtain a suﬃcient number of analyzable meta-
phase cells before making an accurate laboratory
diagnosis of abnormal human chromosomes that have
been altered by disease or cancer mechanisms. This lengthy
and ineﬃcient process can also cause delay to the treatment
of patients. Therefore, developing a computerized scheme
could potentially signiﬁcantly speed up the process of
searching for and identifying analyzable chromosomes. It
may also help cytogeneticists improve the diagnostic per-
formance and minimize inter- and intra-reader variability.Fig. 1. Digital images of two metaphase chromosome cells in which (a) is
considered un-analyzable cells that will be deleted and (b) is an analyzable
cell that will be selected to perform karyotyping.Since 1980s a number of research groups has developed
and tested diﬀerent computerized schemes to analyze chro-
mosome images including identifying analyzable meta-
phase cells, separating overlapped chromosomes,
classifying diﬀerent chromosomes (karyotyping), and
detecting abnormal patterns depicted on the chromosomes.
The detailed discussion of the previous studies (including
the advantages and limitations of these studies) has been
reported in a previously published review article [12]. For
examples, one study developed an Athena system to
semi-automatically identify analyzable metaphase chromo-
somes [13]. The second study reported an automated kary-
otyping system (AKS) using a novel recursive searching
algorithm [14]. The third study developed a scheme to rec-
ognize metaphase spreads from nuclei and artifacts in
microscopic images acquired at 10· magniﬁcation power
with approximately 91% recognition rate [15]. The fourth
study developed an automatic metaphase ﬁnder and
reported a true positive rate of 80% with a false positive
rate of 20% [16]. The ﬁfth group used texture features to
classify manually segmented objects into metaphase
spreads with approximately true positive rate of 85% [17].
The sixth group applied a wavelet-based algorithm to
improve the salient features of chromosome images for
the better diagnosis [18]. This group also developed and
reported a subspace-based model to classify chromosomes
into 24 types after applying the semi-automated methods to
pre-process all individual chromosomes (including straight-
ening the bending chromosomes and identifying the orien-
tation of p-arm of each chromosome) [19]. In addition,
diﬀerent statistical models and machine learning classiﬁers
(i.e., artiﬁcial neural network and probabilistic Markov
network) based on an optimal feature vector or pixel value
distribution have been trained and implemented in comput-
erized schemes to detect (or identify) abnormal patterns of
chromosomes [20–23]. The success of the schemes for
detecting chromosomal aberrations depends on several
pre-conditions including that the analyzable metaphase
chromosomes have been identiﬁed and the individual chro-
mosomes have been separated (without overlapping) and
correctly oriented (i.e., straightening the bending chromo-
somes and knowing p-arms). As a result, when applying
these schemes to real clinical images, human intervention
is often required to select analyzable chromosomes [24].
For examples, since early 1990s, several research groups
have tested the feasibility of applying the semi-automated
computer systems to detect aberrant chromosomes in dif-
ferent clinical images [25,26].
Despite the considerable research eﬀort in developing
computerized schemes to analyze chromosome images,
one of the most importantly clinical issues of how to auto-
matically and robustly detecting and identifying analyzable
metaphase chromosomes depicted on the original micro-
scopic sample slides remains un-solved. As a result, the
technologists in genetic laboratories still visually search
for and identify analyzable metaphase chromosomes in
the routine clinical practice to date. In this study, we
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to identify metaphase chromosome cells depicted on micro-
scopic digital images and to classify them into analyzable
and un-analyzable cells. The purpose of this study is to
develop a simple and robust scheme that has potential to
replace the time-consumed visual searching process. This
scheme can also be the ﬁrst and important step in develop-
ing other fully automated schemes for chromosome image
analysis and diagnosis.Fig. 2. A ﬂow diagram of a computerized scheme to segment chromo-
somes and classify metaphase cells into analyzable and un-analyzable cells.2. Materials and methods
From a clinical database established at a genetic labora-
tory of University of Oklahoma Health Science Center, a
cytogeneticist randomly selected 100 metaphase cells as
one dataset (which was later used as a training dataset)
and then selected another dataset involving 70 metaphase
cells (a testing dataset). An optical microscope equipped
with an objective of 100· magniﬁcation power and a digital
camera was used to acquire digital images of these selected
metaphase chromosome cells. These images have average
size of 768 · 576 pixels and the size of each pixel on the sur-
face of the slides is approximately 0.2 lm · 0.2 lm. In the
training dataset, 35 cells are considered (visually recognized
as) analyzable and 65 are un-analyzable by the cytogeneti-
cist. In the test dataset, 37 cells are analyzable and 33 are
un-analyzable, respectively. These visual classiﬁcation
results were saved in a ‘‘truth’’ ﬁle that is used as a stan-
dard to train our computerized scheme and test its
performance.
Our computerized scheme includes ﬁve image processing
and feature classiﬁcation stages to segment chromosome
areas and to identify analyzable metaphase cells (Fig. 2).
First, the scheme uses an image ﬁlter to pre-process the
images that aims to enhance the image quality (i.e.,
increase signal-to-noise ratio). Because a median ﬁlter is a
simple and eﬀective ﬁlter to reduce random image noise
while preserving image sharpness (minimizing image blur-
ring) [27], we implement a median ﬁlter (with window size
of 5 · 5 pixels) in the scheme to reduce the noise and arti-
fact background in the originally digital chromosome
images. Second, an adjustable threshold is applied to
remove all pixels with gray (digital) values smaller than
the threshold (because chromosomes in metaphase stages
usually have greater gray value than majority of artifacts
in the background). Third, a 4-connectivity component
labeling algorithm and a raster scanning method are
applied to label and group the detected pixels into con-
nected areas and delete the isolated pixels. The rationale
of selecting the 4-connectivity component labeling algo-
rithm is because it is less sensitive to the image noise (or
broken pixels) comparing to other labeling algorithm
(e.g., 8-connectivity component labeling algorithm) [27].
Fourth, the scheme computes following ﬁve image features
from the labeled regions in each microscopic digital image.1. The number of labeled regions: the scheme counts the
total number of labeled regions (NM) in one image
slide.
2. The size of each labeled region: it is deﬁned by counting
the number of pixels involved in the region (Si = NM).
3. The circularity of each labeled region: based on the size
of the region (NM), the scheme deﬁnes an equivalent cir-
cle originating at the gravity center of the region. For a
circle with the same size as the labeled region, the scheme
computes the number of pixels that are located inside the
region contour and the circle (NC). The circularity is
deﬁned as Ci ¼ NCNM, the ratio of the region pixels covered
by the circle and the total pixels inside the labeled region
[28].
4. Average gray value of each labeled region: it is com-
puted as an average digital value of pixels
Iave ¼ 1n
Pn
i¼1I i
 
.
5. The radial length of each region to the cell center: it is
deﬁned as the distance between the gravity center (xc,yc)
of total labeled regions in the image (center of a cell) and
the center of one individual region (xk,yk). It is com-
puted as Lk ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ðxc  xkÞ2 þ ðyc  ykÞ2
q
.
In these ﬁve features, feature #1 is global feature of the
metaphase cell and the rest of four features are computed
for each individual chromosome.
In the last stage of the scheme, a machine learning clas-
siﬁer is applied to identify analyzable metaphase chromo-
somes and delete un-analyzable ones. Two classiﬁers, a
decision tree (DT) and an artiﬁcial neural network
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the most widely used and practical methods for inductive
inference, which approximates discrete-valued functions
that is robust to noisy data and is capable of learning dis-
junctive expressions. ANN is loosely motivated by biolog-
ical neural systems to learn the real-valued and discrete-
valued functions from noisy or incomplete samples. In par-
ticular, the training algorithm of back-propagation using
gradient descent can turn ANN parameters to best ﬁt a
training set of input–output pairs. The limitations of these
two classiﬁers include potentially inductive bias for DT and
over-ﬁtting for ANN. The detailed mathematic founda-
tions and characteristics (including advantages and limita-
tions) of DT and ANN can be found elsewhere [29].
Despite the potential limitations, DT and ANN are two
of the most popular machine learning classiﬁers imple-
mented in the computerized schemes for biomedical images
including chromosome images [12].
DT implemented in this study is constructed based on
the ﬁve computed features and used to classify which digi-
tal image depicts an analyzable metaphase chromosome
cell or not. The structure of the DT is demonstrated in
Fig. 3. This DT uses a simple classiﬁcation criterion: ana-
lyzable metaphase chromosome cells contain more recog-
nizable individual chromosomes than un-analyzable cells.
The DT includes four (horizontal) layers (rows). The ﬁrst
layer includes a start node. The ﬁve computed images fea-
tures are connected to the ﬁve nodes listed in the secondFig. 3. A ﬁve feature based DT for recognizing analyzable and un-analyzable
circularity of each region; F3, average gray value of each region; F4, radial
Nmax = 46; Th2, average size of each region is between Smin = 90 and Smax = 50
each region is PIT = 75; Th5, number of regions is either <Nmin = 19 or
>Smax = 5000; Th7, circularity of each region isPCT = 0.9; Th8, average gray
(the maximum radial length  standard deviation of radial length of all labelerow. The ﬁrst node in this row is the number of labeled
regions. If the number of regions is less than a threshold
value (that is determined by the training dataset), this chro-
mosome image is deﬁned as not analyzable. Only the
images depicted the labeled chromosomes (regions) within
the range between Nmin = 19 and Nmax = 46 are further
analyzed by the following nodes of the DT. Node 2 is the
size of each labeled (individual) region and it aims to delete
some very large connected areas (e.g., S > Smax = 5000)
and very small regions (e.g., S < Smin = 90) in each image.
Node 3 is the circularity of the region and it is designed to
delete the circled regions (e.g., a nucleus) if the circularities
are larger than a pre-determined threshold (e.g.,
C > CT = 0.90). Node 4 is average gray level of the region
and it is used to delete the regions dominated with dirty
substances or cells in each image. In general, the gray value
of chromosomes is larger than those dirty substances and
cells. Hence, if the average gray level of a region is smaller
than the threshold (e.g., Iave < IT = 75), the region is
deleted. Node 5 is the radial length of the region and it
deletes the labeled regions that are far away from the center
of the cell or cluster (e.g., LP Lk = (maximum radial
length  standard deviation of radial length of all labeled
regions)). Since in each of nodes 2–5, the DT may delete
a number of labeled regions and result in the reduction
of the total number of regions remained in one image, this
image (or cell) is analyzed again based on the number of
remaining regions (similar to the node 1) in the third layermetaphase chromosome cells. Note: F1, average size of each region; F2,
length of each region; Th1, number of regions is between Nmin = 19 and
00; Th3, circularity of each region is <CT = 0.9; Th4, average gray value of
>Nmax = 46; Th6, average size of each region is either <Smin = 90 or
value of each region is <IT = 75; Th9, radial length of each region isPLk
d regions); and Th10, radial length of each region is <Lk.
Table 1
Comparison of classiﬁcation results between a cytogeneticist and the DT
based scheme for training dataset
Data classiﬁed
by a cytogeneticist
DT based scheme DT accuracy
rate (%)Correct Wrong
Analyzable cells 35 33 2 94.3
Un-analyzable cells 65 59 6 90.8
Total cells 100 92 8 92.0
Table 2
Comparison of classiﬁcation results between a cytogeneticist and the DT
based scheme for testing dataset
Data classiﬁed
by a cytogeneticist
DT based scheme DT accuracy
rate (%)Correct Wrong
Analyzable cells 37 34 3 91.9
Un-analyzable cells 33 32 1 96.9
Total cells 70 66 4 94.3
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of decision nodes.
The second classiﬁer tested in this study is an ANN.
Unlike the DT (Fig. 3) that uses the features computed
from the individual chromosomes, the ANN only uses
the features computed from all labeled regions in one
acquired image region of interest (ROI). The ANN has a
simple three-layer feed-forward topology. The input layer
includes six neurons that are represented by six features,
which are (1) the number of labeled regions; (2) the average
size of all labeled regions; (3) the standard deviation of
region size; (4) the average pixel value of all regions; (5)
the standard deviation of pixel values; and (6) the average
radial length of all regions. The hidden layer of the ANN
involves three neurons and the output layer contains one
decision neuron. A standard back-propagation training
algorithm is used to train the ANN. Due to the limited size
of our training dataset and in order to minimize over-ﬁtting
and keep the robustness of the ANN performance when
applied to new testing cases, a limited number of training
iterations as well as a large ratio between the momentum
and learning rate is used [30]. Hence, we limit the training
iterations to 400; while the momentum and learning rate
are set at 0.9 and 0.01, respectively. For each training or
testing sample (chromosome cell), the ANN generates a
classiﬁcation score in the range from 0 to 1, where 0 means
deﬁnitely un-analyzable and 1 indicates easily analyzable.
Diﬀerent methods are applied to assess the performance
of two classiﬁers. When using DT, we tabulated the exper-
imental data and computed the Kappa coeﬃcients for
agreement of the classiﬁcation results between the cytoge-
neticist and the computerized scheme. The performance
of using ANN to classify metaphase chromosome cells is
evaluated using receiver operating characteristics (ROC),
a standard method widely used to evaluate the perfor-
mance of observers and computerized schemes in diagnosis
and analysis of biomedical images [31]. A computer pro-
gram converts the ANN-generated classiﬁcation scores of
all analyzable (‘‘positive’’) and un-analyzable (‘‘negative’’)
samples in one dataset (either training or testing) into
two histograms with 11 bins. Based on these two histo-
grams (one for positive cases and one for negative cases),
an un-smoothed ROC-type performance curve can be plot-
ted. ROCFIT program [32] that uses maximum likelihood
estimation method [33] is then used to ﬁt ROC data (curve)
and compute an area under the ROC curve (AZ value), an
index to measure the scheme performance. Because two
datasets were independently selected and size of each data-
set is relatively small, two datasets may have substantially
diﬀerent distribution of image feature characteristics. To
better estimate the performance of our scheme and mini-
mize the potential bias when using an ANN as a classiﬁer,
we also applied a 2-fold cross-validation method to assess
scheme performance. We trained and tested the ANN twice
by switching between training and testing dataset, which
means that each of two datasets is used once for training
and once for testing. The testing classiﬁcation score of eachcell region is used to generate the ﬁnal ROC curve for the
complete dataset using ROCFIT program.3. Results
The diﬀerence of classiﬁcation results between the
‘‘truth’’ (provided by the cytogeneticist) and the DT based
scheme for both training and testing datasets is summa-
rized and compared (as shown in Tables 1 and 2). The
results indicate that 92.0% (92 out of 100) and 94.3% (66
out of 70) of queried cell regions in the training and testing
datasets are assigned to the same group (either ‘‘analyz-
able’’ or ‘‘un-analyzable’’) by both the cytogeneticist in
our genetic laboratory and DT based classiﬁer. The corre-
sponding Kappa coeﬃcients for agreement are 0.83 and
0.89 for the training and testing datasets, respectively. Spe-
ciﬁcally, the DT based scheme achieves 94.3% (33 out of
35) of detection sensitivity (‘‘true-positive’’ classiﬁcation
rate) and 90.8% (59 out of 65) of speciﬁcity (‘‘true-nega-
tive’’ classiﬁcation rate) for the training dataset. For the
testing dataset, the sensitivity and speciﬁcity are 91.9%
(34 out of 37) and 96.9% (32 out of 33), respectively.
To verify the feature distribution diﬀerence between two
datasets, we plotted a series of scatter diagrams between
diﬀerent pairs of features. For example, the scatter dia-
grams between the features of average pixel values and
the number of labeled regions are shown in Figs. 4 and 5
for the original training and testing dataset. For these
two features the analyzable cells are mostly located in the
up-right corner of the diagram (which indicated the larger
number of labeled regions and higher pixel value). Com-
paring between Figs. 4 and 5, we ﬁnd that in the initial
training dataset used for DT based classiﬁer; several un-
analyzable cells also involve larger number of labeled
regions and higher average pixel values. These ‘‘diﬃcult’’
un-analyzable cells reduce the classiﬁcation performance
Fig. 4. A scatter diagram between two features of 100 training samples
including 35 analyzable (‘‘positive’’) and 65 un-analyzable (‘‘negative’’)
cells.
Fig. 5. A scatter diagram between two features of 70 testing samples
including 37 analyzable (‘‘positive’’) and 33 un-analyzable (‘‘negative’’)
cells.
Fig. 6. The distribution of the computed performance points for two data
subsets (‘‘training’’ and ‘‘test’’ subsets) and the complete dataset. A ROC-
type performance curve was generated based on ﬁtting of the complete
dataset using ROCFIT program.
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the classiﬁcation performance on the initial testing dataset
(as shown in Fig. 6). A ROC curve generated based on
complete dataset using 2-fold cross-validation method is
also plotted in Fig. 6. The computed AZ values (the areas
under ROC curve) are 0.918 ± 0.015, 0.942 ± 0.013, and
0.930 ± 0.008, for the original training, testing, and com-
plete dataset, respectively.4. Discussion
Because of its advantages and eﬀectiveness over tradi-
tionally anatomical imaging modalities and techniques in
detecting cancers and monitoring cancer treatment eﬃcacy,molecular and chromosome imaging have been attracted
extensive research interests. Chromosomal disorder is a
powerful indicator in diagnosis of cancers (i.e., leukemia,
skin and breast cancers) and other genetic diseases.
Although identiﬁcation of chromosomal aberrations (dis-
orders) is routinely performed in the clinical laboratories
to provide physicians the diagnostic results and help them
decide and manage optimal therapeutic treatment plans for
patients, this is a very tedious and time-consuming task.
Currently, the laboratory technologists spend more valu-
able time to identify analyzable metaphase chromosome
cells, rather than spend time to identify and analyze the
chromosomal abnormal patterns. Our previous study has
demonstrated that using computerized scheme could
potentially help clinicians more eﬃciently and accurately
diagnose (classify) diﬀerent types of leukemia and predict
the cancer prognosis [34]. However, the precondition of
accurate diagnosis of cancers and genetic diseases using
chromosome images is to identify a set of analyzable (or
diagnosable) metaphase chromosome cells. In addition,
developing a fully automated scheme to detect and identify
analyzable metaphase chromosome cells is the ﬁrst and
probably the most important step to replace tediously man-
ual searching process. Therefore, the motivation and pur-
pose of this study is to develop a computerized scheme
that has potential to replace the manual searching process
and meet the requirement of other semi-automated
schemes in chromosome classiﬁcation by automatically
identifying analyzable metaphase chromosomes depicted
on microscopic digital images.
For this purpose, we developed and tested a simple and
unique computerized scheme. The scheme was directly
optimized and applied to the originally cultured chromo-
some images used for the standard (or banded) chromo-
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tory for the diagnosis of cancers and genetic diseases. This
approach of using real clinical images without pre-process-
ing increases the application potential and robustness of
our scheme in the clinical environment. We are aware that
when diﬀerent cultured or sample preparation methods are
used in diﬀerent laboratories for diﬀerent diagnostic pur-
pose, the banded patterns of the chromosomes could be
diﬀerent. However, this does not aﬀect our scheme to
detect and identify analyzable metaphase chromosomes
because no speciﬁc band features and absolute size features
of individual chromosomes are used in our scheme. Our
scheme was also applied to the high-resolution (or high
magniﬁcation) microscopic digital images. Comparing with
previously reported studies using low-resolution images,
which could only alert the laboratory technologists the
location of potentially analyzable chromosome cells and
visual examination is needed by switching to another
microscopic objective with high magniﬁcation power to
determine whether the cell is analyzable or not [15], our
approach has two advantages. First, the analyzable meta-
phase chromosome cells detected and prompted by the
scheme can be directly examined and analyzed by technol-
ogists (or cytogeneticists) for the diagnosis purpose without
using the microscope. Second, the identiﬁed analyzable
metaphase chromosomes can be used by other computer-
aided diagnosis scheme to potentially perform more com-
prehensive tasks (i.e., the detection of the distortion in
chromosomes’ banded patterns). Hence, our scheme can
be integrated with other available semi-automated schemes
to develop fully automated computer schemes in the future
studies.
During the development and evaluation of a computer
scheme involving a machine learning classiﬁer, the
researchers often face a number of biases, in particular
the bias of case (learning sample) selection and validation
method. We took several measures (procedures) in an
attempt to avoid or minimize the bias of the classiﬁcation
results. First, the training and testing datasets used in this
study were independently selected in our genetic laboratory
by cytogeneticists. The researchers who developed and
tested the computerized scheme did not involve in the case
selection, which helps eliminate the bias in case selection.
Second, due to the limitation of size of the dataset, avoid-
ing or minimizing the bias in classiﬁcation results (e.g., due
to the potential over-training) is always a diﬃcult chal-
lenge. Several optimization (training and testing) methods
including jackkniﬁng (leave-one-out), N-fold cross-valida-
tion, and use of independent testing dataset have been
widely used in development and optimization of the com-
puterized schemes. Previous studies have suggested that
both leave-one-out and cross-validation methods were
more likely to generate considerable bias and variance
[35,36]. Although using independent testing dataset is the
best way to reduce the classiﬁcation bias, dividing limited
dataset into two independent datasets reduces the size
and diversity of training dataset and may also reduce theperformance of testing result [35]. As a result, to minimize
the classiﬁcation bias and assess the optimal performance
of the scheme, we used both independent testing and 2-fold
cross-validation methods in this study.
The results of this preliminary study are encouraging.
The scheme achieved high performance on an independent
testing dataset (i.e., Kappa = 0.89 for using the DT based
classiﬁer and AZ > 0.93 for using the ANN-based classi-
ﬁer). The results indicated that the scheme could correctly
identify more than 90% of analyzable chromosome cells
while eliminating majority of un-analyzable cells (e.g.,
>85%). However, there are several limitations in this study.
First, the size of datasets was relatively limited (small). Sec-
ond, the ‘‘truth’’ was determined by one cytogeneticist in
our genetic laboratory. The issue of potential inter-obser-
ver variability has not been investigated. Third, all micro-
scopic digital images of chromosomes were pre-selected
and each image depicts one metaphase cell (either analyz-
able or un-analyzable one). In our future studies, we will
further optimize and test our scheme using a much large
and diverse image database. The ‘‘truth’’ ﬁle will be veriﬁed
by a panel of cytogeneticists. We will also test and apply
this scheme to the sequential images automatically
acquired by a high-speed microscopic image scanner (that
is currently under development in our laboratory). The
new computerized scheme should ﬁrst detect whether an
image depicts a metaphase cell or not, since in the clinical
environment most of images acquired by a high-speed
microscopic image scanner contain no metaphase cells.
After the metaphase cells are detected, the scheme then
identiﬁes analyzable metaphase cells and discards un-ana-
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